257 related articles for article (PubMed ID: 32474915)
21. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
22. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
23. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
Milde-Langosch K; Riethdorf S; Kraus-Pöppinghaus A; Riethdorf L; Löning T
Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
[TBL] [Abstract][Full Text] [Related]
24. HPV genotyping in adenocarcinoma of the uterine cervix in Thailand.
Siriaunkgul S; Utaipat U; Suthipintawong C; Tungsinmunkong K; Triratanachat S; Khunamornpong S
Int J Gynaecol Obstet; 2013 Dec; 123(3):226-30. PubMed ID: 24095305
[TBL] [Abstract][Full Text] [Related]
25. Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas.
Wong RW; Ng JHY; Han KC; Leung YP; Shek CM; Cheung KN; Choi CKM; Tse KY; Ip PPC
Mod Pathol; 2021 Jan; 34(1):207-221. PubMed ID: 32699256
[TBL] [Abstract][Full Text] [Related]
26. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases.
Pirog EC; Lloveras B; Molijn A; Tous S; Guimerà N; Alejo M; Clavero O; Klaustermeier J; Jenkins D; Quint WG; Xavier Bosch F; Alemany L; de Sanjosé S;
Mod Pathol; 2014 Dec; 27(12):1559-67. PubMed ID: 24762548
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract][Full Text] [Related]
28. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
[TBL] [Abstract][Full Text] [Related]
30. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin.
Plunkett M; Brestovac B; Thompson J; Sterrett G; Filion P; Smith D; Frost F
Pathology; 2003 Oct; 35(5):397-401. PubMed ID: 14555383
[TBL] [Abstract][Full Text] [Related]
31. The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.
Chen W; Sun H; Molijn A; Zeng L; Kang L; Jenkins D; Zhang S; Cui J; Wu Z; Pirog E; Shen G; Zhang X; Qiao Y;
J Low Genit Tract Dis; 2018 Oct; 22(4):355-361. PubMed ID: 30074955
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
33. Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix.
Toki T; Zhai YL; Park JS; Fujii S
Int J Gynecol Pathol; 1999 Jul; 18(3):215-9. PubMed ID: 12090589
[TBL] [Abstract][Full Text] [Related]
34. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
35. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study.
An HJ; Kim KR; Kim IS; Kim DW; Park MH; Park IA; Suh KS; Seo EJ; Sung SH; Sohn JH; Yoon HK; Chang ED; Cho HI; Han JY; Hong SR; Ahn GH
Mod Pathol; 2005 Apr; 18(4):528-34. PubMed ID: 15502807
[TBL] [Abstract][Full Text] [Related]
37. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus and mixed epithelial tumors of the endometrium.
O'Leary JJ; Landers RJ; Crowley M; Healy I; O'Donovan M; Healy V; Kealy WF; Hogan J; Doyle CT
Hum Pathol; 1998 Apr; 29(4):383-9. PubMed ID: 9563789
[TBL] [Abstract][Full Text] [Related]
39. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Woods J; Finkelstein SD
Int J Gynecol Pathol; 2000 Apr; 19(2):110-7. PubMed ID: 10782406
[TBL] [Abstract][Full Text] [Related]
40. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]